Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

TTP Labtech Technology IDs Novel Drug Candidates for Neuropsychiatric Disorders

July 25, 2014 2:50 pm | News | Comments

The first high-resolution X-ray crystal structure of the metabotropic glutamate receptor 5 transmembrane domain was reported in Nature this week. The work was performed at Heptares Therapeutics using TTP Labtech’s innovative liquid handling technology for lipidic cubic phase crystallography. Read more...

TOPICS:

SRI Snags NIH Contract for HIV, AIDS Therapies

July 25, 2014 2:47 pm | News | Comments

SRI International has been awarded a new $49 million, seven-year contract with the NIAID, part of the NIH, to conduct preclinical development of potential therapies for HIV infection and AIDS. Read more...              

TOPICS:

EPFL, Nearmedic Pharma Partner to Fight Tuberculosis

July 25, 2014 2:42 pm | News | Comments

The pharmaceutical company Nearmedic is collaborating with EPFL to participate in the development of a treatment against tuberculosis. Read more...                             

TOPICS:
Advertisement

‘Broken Genes’ for a Broken System

July 25, 2014 2:30 pm | News | Comments

The recent discovery of a genetic mutation that protects against type 2 diabetes may offer hope in fighting more than just diabetes. It also illustrates how using the tools of genetics to hunt for “broken genes” can aid drug discovery, according to a Harvard professor. Read more...

TOPICS:

More U.S. Girls Now Getting Cervical Cancer Vaccine

July 25, 2014 2:20 pm | News | Comments

More teen girls are getting a controversial cervical cancer vaccine but the increase isn't much of a bump, the government reported Thursday. Read more...                            

TOPICS:

Bio-Rad Introduces Bio-Plex Pro RBM Human Metabolic and Hormone Assays

July 25, 2014 2:08 pm | Product Releases | Comments

Bio-Rad Laboratories Inc. announced the launch of its new Bio-Plex Pro RBM Human Metabolic and Hormone Assays, developed in partnership with Myriad RBM, Inc. Read more...

ChromaTrap Helps Advance Research into Women's Reproductive Health

July 25, 2014 1:41 pm | Product Releases | Comments

An informative video interview with Professor Steve Conlan of the College of Medicine at Swansea University (UK) highlights the latest research developments in women’s reproductive health using unique molecular biology tools, and another video interview with Steve Knight of Porvair Sciences demonstrates the utility of the ChromaTrap solid state ChIP assay. Read more...

Humira Lifts AbbVie 2.8% in Q2

July 25, 2014 12:00 pm | by The Associated Press | News | Comments

Drugmaker AbbVie Inc.'s second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira. Read more...                      

TOPICS:
Advertisement

CHMP Recommends MA for Diabetes Drug

July 25, 2014 11:24 am | News | Comments

Novo Nordisk announced that the Committee for Medicinal Products for Human Use under the European Medicines Agency adopted a positive opinion, recommending marketing authorization for Xultophy for the treatment of type 2 diabetes mellitus in adults. Read more...

TOPICS:

FDA Reviews What Could Be First Biosimilar

July 25, 2014 11:20 am | News | Comments

The Food and Drug Administration is reviewing research data on what could become the first U.S.-approved "biosimilar" drug, a cheaper, sort-of generic version of a biologic drug, nearly five years after Congress passed a law enabling future approval of biosimilars. Read more...

TOPICS:

Blood Cancer Drug Gets Positive CHMP Opinion

July 25, 2014 11:09 am | News | Comments

Gilead Sciences Inc. announced that the Committee for Medicinal Products for Human Use has adopted a positive opinion on the company's Marketing Authorization Application for Zydelig, a first-in-class treatment for patients with chronic lymphocytic leukemia and follicular lymphoma. Read more...

TOPICS:

Genomics Reveals Mechanism for Malaria Drug Resistance

July 25, 2014 10:58 am | News | Comments

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug, a  discovery made at Washington University School of Medicine in St. Louis that also is relevant for other infectious diseases including bacterial infections and tuberculosis. Read more...

TOPICS:

Sorafenib, Capecitabine Combo Fails to Meet Endpoint

July 25, 2014 10:49 am | News | Comments

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals Inc., an Amgen subsidiary, announced that an investigational Phase 3 trial of sorafenib (Nexavar) tablets plus capecitabine in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival. Read more...

TOPICS:

Pfizer’s Attempted AstraZeneca Deal Gets Obama’s Attention

July 25, 2014 10:42 am | News | Comments

Staking out a populist stand ahead of the midterm elections, President Barack Obama on Thursday demanded "economic patriotism" from U.S. corporations that use legal means to avoid U.S. taxes through overseas mergers, declaring "I don't care if it's legal. It's wrong." Read more...

TOPICS:

Metastatic Brain Tumor Treatment Could Be on the Horizon

July 24, 2014 3:19 pm | News | Comments

Over half of patients being seen in the clinic for a diagnosed brain tumor have metastatic cancer, which has no treatment and detrimental outcomes in most cases. However, a new study provides hope that previously studied SapC-DOPS could be used for treatment of brain cancer that has spread. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading